Skip to main content

Day: May 4, 2022

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022

Initiated EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis  Described new understanding of α4β7-expressing immune cells and MORF-057 dose response in oral presentation at ECCO 2022 Announced key appointments and advancements in leadership team Ended first quarter 2022 with $381 million in cash and equivalents, providing runway through year-end 2024 WALTHAM, Mass., May 04, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the first quarter of 2022. First Quarter 2022 and Recent Corporate HighlightsLaunched EMERALD-1 (MORF-057-201) phase 2a studyEMERALD-1 is an open-label multi-center study of MORF-057...

Continue reading

Pacira BioSciences Reports First Quarter 2022 Financial Results

— First quarter revenue of $158 million, up 33% over prior year —— Strong topline performance delivers net income and significantly positive adjusted EBITDA —— Conference call today at 8:30 a.m. ET — TAMPA, Fla., May 04, 2022 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2022. First Quarter 2022 Financial HighlightsTotal revenues of $158.0 million Net product sales of $129.2 million for EXPAREL, $23.6 million for ZILRETTA, and $3.0 million for iovera° Net income of $6.8 million, or $0.15 per share (basic and diluted) Adjusted EBITDA of $53.8 million, or $1.20 per share (basic) and $1.16 per share (diluted)“We were delighted...

Continue reading

Live Ventures to Release Fiscal Second Quarter Financial Results on May 11, 2022

LAS VEGAS, May 04, 2022 (GLOBE NEWSWIRE) — Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal second quarter ended March 31, 2022, before the opening of the NASDAQ Stock Market on Wednesday, May 11, 2022. About Live VenturesLive Ventures is a growing, diversified holding company with a strategic focus on value-oriented acquisitions of domestic middle-market companies. Live Ventures’ acquisition strategy is sector agnostic and focuses on well-run, closely held businesses with a demonstrated track record of earnings growth and cash flow generation. The Company looks for opportunities to partner with management teams of its acquired businesses to build increased stockholder value through a disciplined buy-build-hold long-term...

Continue reading

BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022

SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the three months ended March 31, 2022 and provide a corporate update by conference call on Wednesday, May 11, 2022 at 4:30 PM ET. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference by navigating to https://dpregister.com/sreg/10166913/f2b2448b7e. Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call...

Continue reading

Allegro MicroSystems Achieves Major Milestone of Three Billion Motor Driver Integrated Circuits Shipped

New innovations help customers increase efficiency and reduce costs while helping them to achieve higher safety standardsThree Billion Motor Driver ICs Shipped! Allegro MicroSystems Achieves Major Milestone of Three Billion Motor Driver Integrated Circuits ShippedManchester, NH, USA, May 04, 2022 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in sensing and power solutions for motion control and energy-efficient systems, today announced that it has shipped its three billionth motor driver integrated circuit (IC), underpinning the strength of its motion control business. The company’s trusted and reliable motor drivers have helped customers around the world innovate safer, more robust motor-drive solutions with increased reliability. They can be found across automotive, industrial,...

Continue reading

Cemtrex Announces New Strategic Focus to Address Significant Near-Term Opportunities

Evaluating a Range of Operational and Financial Alternatives Including the Sale of One Or More of the Company’s Business Units Brooklyn, NY, May 04, 2022 (GLOBE NEWSWIRE) —  – Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, today announced a strategic shift towards prioritizing its core businesses, in particular Vicon Industries, its security technology brand to maximize shareholder value, drive long term growth, and profitability. In conjunction with the strategy shift to bolster its Advanced Technologies segment, Cemtrex is exploring the divestiture of one or more business units to support its refocus. Chairman and CEO, Saagar Govil commented, “After a thorough strategic...

Continue reading

IBN (InvestorBrandNetwork) Coverage Initiated for Golden Matrix Group Inc.

LOS ANGELES, May 04, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Golden Matrix Group Inc. (NASDAQ: GMGI), an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators, today announces it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. Golden Matrix Group develops fully operational, turnkey online casino solutions as well as highly modular, configurable and scalable gaming platforms for its international customers in an effort to promote user acquisition, engagement, retention and monetization. The provided white label gaming platforms are unparalleled in both mobile and desktop website deployment, proving compatible throughout all major operating systems...

Continue reading

Reed’s Schedules First Quarter 2022 Conference Call for May 16, 2022 at 5:00 p.m. ET

NORWALK, Conn., May 04, 2022 (GLOBE NEWSWIRE) —  Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger beverages, will host a conference call on Monday, May 16, 2022 at 5:00 p.m. Eastern time to discuss its financial results for the three months ended March 31, 2022. The Company’s results will be reported in a press release prior to the call. Reed’s management will host the conference call, followed by a question-and-answer period. Date: Monday, May 16, 2022Time: 5:00 p.m. Eastern timeToll-free dial-in number: (844) 850-0544International dial-in number: (412) 542-4115Conference ID: 10166575Webcast: Reed’s Q1 2022 Conference Call Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization....

Continue reading

CyberloQ Technologies, Inc. Issues Shareholder Update on Technology Status

Sarasota, FL, May 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — CyberloQ Technologies, Inc. (“CyberloQ” or the “Company”) ( CLOQ ) is pleased to announce the following update on the Company’s business and information objectives going forward. By way of analogy, if software were a truck, we are wrapping up the engineering and development of the chassis, engine, transmission and the drive train – in other words, the “power plant” that is the core foundation of the truck.  “In software, we refer to this as the Back-End architecture and capability,” stated Shawn Watts, who’s leading the development team.” Continuing the analogy, once the power plant is complete, we will turn our full attention to the design and development of the suspension and steering, exterior body, and everything in the passenger...

Continue reading

SCYNEXIS to Present New Data of Ibrexafungerp for Refractory Vulvovaginal Candidiasis from Ongoing Phase 3 FURI Study at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting

Product theater presentation will be held on May 7 to highlight clinical data and attributes of the first new antifungal class approved in more than 25 years JERSEY CITY, N.J., May 04, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, will present new data from its ongoing FURI study of ibrexafungerp during the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting being held in San Diego, May 6-8, 2022. “We are excited to attend this important meeting, which brings together many of the top medical minds in the OB/GYN field,” said Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS. “We look forward to sharing details about our latest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.